Financial Health Scores: Healthcare

Top Healthcare companies by financial health score. Each score is a 0-100 composite of six dimensions ranked as percentiles within the company's peer group (banks against banks, REITs against REITs), so it measures standing among peers rather than absolute cross-industry strength.

Rates the quality of the business, not whether the stock is cheap. A 0–100 composite of profitability, growth, leverage, liquidity, cash flow, and returns.

A high score means strong fundamentals, but not a guaranteed good trade. A great business can still be a bad buy at the wrong price.

Banks, REITs, insurers, and early-stage companies are scored on sector-tailored metrics. Full methodology →

Research tool, not financial advice. Use alongside valuation analysis and your own view of the business.

Data as of FY 2025 100 companies Rhea AI

# Company Dimensions

SLGL Sol-Gel Technologies L… Emerging 91 Cash Dil R&D RevPS Burn BalSh 5/9 Safe 2

CPRX Catalyst Pharmaceutica… Check Earnings 89 Profit Growth Debt Cash Flow Return 4/9 Safe 3

UTHR United Therapeutics Co… 88 Profit Growth Debt Cash Flow Return 7/9 Safe 4

FULC Fulcrum Therapeutics, … Emerging Check Earnings 88 Cash Dil R&D RevPS Burn BalSh 5/9 Safe 5

DOCS Doximity, Inc. 88 Profit Growth Debt Cash Flow Return 5/9 Safe 6

RMD ResMed Inc. 87 Profit Growth Debt Cash Flow Return 8/9 Safe 7

HRMY Harmony Biosciences Ho… 87 Profit Growth Debt Cash Flow Return 5/9 Safe 8

ISRG Intuitive Surgical, In… 86 Profit Growth Debt Cash Flow Return 7/9 Safe 9

IRMD IRADIMED CORPORATION 86 Profit Growth Debt Cash Flow Return 5/9 Safe 10

INVA Innoviva, Inc. Check Earnings Data Issue 83 Profit Growth Debt Cash Flow Return 5/9 Safe 11

ANAB AnaptysBio, Inc. Emerging Check Earnings One-time Loss 83 Cash Dil R&D RevPS Burn BalSh 5/9 Grey 12

STOK Stoke Therapeutics, In… Emerging Check Earnings 82 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 13

CGEN Compugen Ltd. Emerging Check Earnings 82 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 14

QTTB Q32 Bio Inc. Emerging Check Earnings Data Issue 81 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 15

LMAT LeMaitre Vascular, Inc… 81 Profit Growth Debt Cash Flow Return 6/9 Safe 16

HNGE Hinge Health, Inc. Emerging Data Issue 81 Cash Dil R&D RevPS Burn BalSh 4/9 Grey 17

ADMA ADMA Biologics, Inc. Check Earnings 81 Profit Growth Debt Cash Flow Return 5/9 Safe 18

NUTX Nutex Health Inc. One-time Loss 80 Profit Growth Debt Cash Flow Return 7/9 Safe 19

NBIX Neurocrine Biosciences… 80 Profit Growth Debt Cash Flow Return 4/9 Safe 20

CUE Cue Biopharma, Inc. Emerging Check Earnings 80 Cash Dil R&D RevPS Burn BalSh 5/9 Distress 21

UTMD Utah Medical Products,… 79 Profit Growth Debt Cash Flow Return 6/9 Safe 22

REGN Regeneron Pharmaceutic… 79 Profit Growth Debt Cash Flow Return 4/9 Safe 23

NMTC NeuroOne Medical Techn… Emerging Check Earnings Data Issue 79 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 24

EXEL Exelixis, Inc. 79 Profit Growth Debt Cash Flow Return 6/9 Safe 25

DCTH Delcath Systems, Inc. Emerging Data Issue 79 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 26

TBPH Theravance Biopharma, … Emerging Data Issue 78 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 27

SMLR Semler Scientific, Inc… Check Earnings 78 Profit Growth Debt Cash Flow Return 3/9 Safe 28

HALO Halozyme Therapeutics,… 78 Profit Growth Debt Cash Flow Return 5/9 Safe 29

CORT Corcept Therapeutics I… 78 Profit Growth Debt Cash Flow Return 4/9 Safe 30

GMED Globus Medical, Inc. 77 Profit Growth Debt Cash Flow Return 7/9 Safe 31

ELMD Electromed, Inc. 77 Profit Growth Debt Cash Flow Return 7/9 Safe 32

WST West Pharmaceutical Se… 76 Profit Growth Debt Cash Flow Return 7/9 Safe 33

MIRM Mirum Pharmaceuticals,… Emerging 76 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 34

MDXG MiMedx Group, Inc. Data Issue 76 Profit Growth Debt Cash Flow Return 5/9 Safe 35

IDXX IDEXX Laboratories, In… 76 Profit Growth Debt Cash Flow Return 8/9 Safe 36

BMRN BioMarin Pharmaceutica… 76 Profit Growth Debt Cash Flow Return 4/9 Safe 37

ARWR Arrowhead Pharmaceutic… Emerging Check Earnings Data Issue 76 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 38

YMAB Y-mAbs Therapeutics, I… Emerging 75 Cash Dil R&D RevPS Burn BalSh 2/9 Safe 39

TXG 10x Genomics, Inc. Emerging 75 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 40

PTGX Protagonist Therapeuti… Emerging 75 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 41

PODD Insulet Corporation 75 Profit Growth Debt Cash Flow Return 6/9 Safe 42

INMD InMode Ltd. 74 Profit Growth Debt Cash Flow Return 3/9 Safe 43

EW Edwards Lifesciences C… 74 Profit Growth Debt Cash Flow Return 6/9 Safe 44

CRON Cronos Group Inc. Emerging Check Earnings 74 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 45

BCRX BioCryst Pharmaceutica… Data Issue 74 Profit Growth Debt Cash Flow Return 7/9 Grey 46

VRTX Vertex Pharmaceuticals… 73 Profit Growth Debt Cash Flow Return 6/9 Safe 47

VRCA Verrica Pharmaceutical… Emerging Check Earnings Data Issue 73 Cash Dil R&D RevPS Burn BalSh 5/9 Distress 48

ANIK Anika Therapeutics, In… Emerging 73 Cash Dil R&D RevPS Burn BalSh 5/9 Safe 49

ALKS Alkermes plc 73 Profit Growth Debt Cash Flow Return 5/9 Safe 50

UFPT UFP Technologies, Inc. 72 Profit Growth Debt Cash Flow Return 7/9 Safe 51

TCMD Tactile Systems Techno… 72 Profit Growth Debt Cash Flow Return 7/9 Safe 52

SRDX Surmodics, Inc. Emerging 72 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 53

KPRX Kiora Pharmaceuticals,… One-time Loss New Filer 72 Profit Growth Debt Cash Flow Return - Distress 54

IDYA IDEAYA Biosciences, In… Emerging Check Earnings 72 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 55

WAT Waters Corporation 71 Profit Growth Debt Cash Flow Return 4/9 Safe 56

NNNN Anbio Biotechnology Check Earnings Data Issue 71 Profit Growth Debt Cash Flow Return 4/9 Safe 57

LNTH Lantheus Holdings, Inc… Check Earnings 71 Profit Growth Debt Cash Flow Return 5/9 Safe 58

LGND Ligand Pharmaceuticals… 71 Profit Growth Debt Cash Flow Return 4/9 Safe 59

TVTX Travere Therapeutics, … Emerging Check Earnings Unit Sold 70 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 60

PULM Pulmatrix, Inc. Emerging Check Earnings 70 Cash Dil R&D RevPS Burn BalSh 3/9 Distress 61

PGNY Progyny, Inc. 70 Profit Growth Debt Cash Flow Return 5/9 Safe 62

KRMD KORU Medical Systems, … Emerging 70 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 63

ANIP ANI Pharmaceuticals, I… 70 Profit Growth Debt Cash Flow Return 7/9 Grey 64

AMPH Amphastar Pharmaceutic… 70 Profit Growth Debt Cash Flow Return 6/9 Grey 65

ADAG Adagene Inc. Emerging 70 Cash Dil R&D RevPS Burn BalSh 2/9 Distress 66

ABT Abbott Laboratories 70 Profit Growth Debt Cash Flow Return 5/9 Safe 67

XOMAO XOMA Royalty Corporati… Emerging 69 Cash Dil R&D RevPS Burn BalSh 6/9 - 68

XOMA XOMA Royalty Corp Emerging 69 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 69

VCYT Veracyte, Inc. 69 Profit Growth Debt Cash Flow Return 7/9 Safe 70

RGEN Repligen Corporation 69 Profit Growth Debt Cash Flow Return 7/9 Safe 71

PEN Penumbra, Inc. 69 Profit Growth Debt Cash Flow Return 6/9 Safe 72

PBYI Puma Biotechnology, In… Check Earnings Data Issue 69 Profit Growth Debt Cash Flow Return 7/9 Distress 73

MMSI Merit Medical Systems,… 69 Profit Growth Debt Cash Flow Return 7/9 Safe 74

KURA Kura Oncology, Inc. Check Earnings New Filer 69 Profit Growth Debt Cash Flow Return 2/9 Distress 75

DXCM DexCom, Inc. 69 Profit Growth Debt Cash Flow Return 7/9 Safe 76

BLFS BioLife Solutions, Inc… Emerging Unit Sold 69 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 77

ADUS Addus HomeCare Corpora… 69 Profit Growth Debt Cash Flow Return 7/9 Safe 78

ZYME Zymeworks Inc. Emerging 68 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 79

ZLAB Zai Lab Limited Emerging 68 Cash Dil R&D RevPS Burn BalSh 3/9 Distress 80

XBIO Xenetic Biosciences, I… Emerging Data Issue 68 Cash Dil R&D RevPS Burn BalSh 3/9 Distress 81

NHC National HealthCare Co… 68 Profit Growth Debt Cash Flow Return 7/9 Safe 82

LXRX Lexicon Pharmaceutical… Emerging Check Earnings Data Issue 68 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 83

KYNB Kyntra Bio, Inc. Emerging Check Earnings Data Issue 68 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 84

HQY HealthEquity, Inc. 68 Profit Growth Debt Cash Flow Return 8/9 Safe 85

HOLX Hologic, Inc. 68 Profit Growth Debt Cash Flow Return 5/9 Safe 86

FGEN FibroGen, Inc. Emerging Check Earnings Data Issue 68 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 87

ACAD ACADIA Pharmaceuticals… Check Earnings 68 Profit Growth Debt Cash Flow Return 5/9 Safe 88

A Agilent Technologies I… 68 Profit Growth Debt Cash Flow Return 5/9 Safe 89

ZVRA Zevra Therapeutics, In… Emerging Check Earnings 67 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 90

VEEV Veeva Systems Inc. 67 Profit Growth Debt Cash Flow Return 6/9 Safe 91

TXMD TherapeuticsMD, Inc. Emerging Check Earnings Data Issue 67 Cash Dil R&D RevPS Burn BalSh 5/9 Distress 92

SYK Stryker Corporation 67 Profit Growth Debt Cash Flow Return 4/9 Safe 93

STE STERIS plc 67 Profit Growth Debt Cash Flow Return 9/9 Safe 94

SPRO Spero Therapeutics, In… Emerging Data Issue 67 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 95

EQ Equillium, Inc. Emerging Check Earnings 67 Cash Dil R&D RevPS Burn BalSh 2/9 Safe 96

ARVN Arvinas, Inc. Emerging Check Earnings 67 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 97

VMD Viemed Healthcare, Inc… 66 Profit Growth Debt Cash Flow Return 6/9 Safe 98

TECH Bio-Techne Corporation 66 Profit Growth Debt Cash Flow Return 5/9 Safe 99

NAMS NewAmsterdam Pharma Co… Emerging 66 Cash Dil R&D RevPS Burn BalSh 2/9 Safe 100

MRSN Mersana Therapeutics, … Emerging Check Earnings Data Issue 66 Cash Dil R&D RevPS Burn BalSh 4/9 -

How the Financial Health Score is calculated

Each company receives a composite score from 0 to 100 built from six dimensions derived from SEC filings. The dimensions are family-specific: a company is scored on the metrics that matter for its business type, then ranked against direct peers rather than across every industry. A score is a company's standing within its peer group, not an absolute cross-industry rating; a 70 for a bank and a 70 for a software company both mean "top of its family," not "equally strong businesses."

Each of the six dimensions is scored as a percentile within the family (how the company ranks against its peers on that dimension). The overall score is the rounded average of the six, with any dimension we can't compute counted as zero out of a fixed denominator of six, so incomplete data can't inflate a ranking.

Operating companies, energy and utilities are scored on Profitability, Growth, Leverage, Liquidity, Cash Flow, and Returns.
Banks are scored on Earnings, Growth, Capital, Efficiency, Credit Quality, and Stability.
Insurers are scored on Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, and Stability.
REITs are scored on FFO Margin, FFO Growth, Leverage, Interest Coverage, AFFO Margin, and Dividend Coverage.
Emerging (pre-profit) companies are scored on Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, and Balance Sheet.
Warrants, preferred shares and duplicate listings that share a parent company's financials are automatically filtered from the ranking.

The Piotroski F-Score (0 to 9) measures fundamental strength using nine binary accounting tests; the Altman Z-Score estimates bankruptcy risk, classifying companies into Safe, Grey, or Distress zones. These two signals are shown alongside the composite score for additional perspective.